Interspecies Organogenesis for Human Transplantation

Andrew T. Crane; Rajagopal N. Aravalli; Atsushi Asakura; Andrew W. Grande; Venkatramana D. Krishna; Daniel F. Carlson; Maxim C.J. Cheeran; Georgette Danczyk; James R. Dutton; Perry B. Hackett; Wei Shou Hu; Ling Li; Wei Cheng Lu; Zachary D. Miller; Timothy D. O’Brien; Angela Panoskaltsis-Mortari; Ann M. Parr; Clairice Pearce; Mercedes Ruiz-Estevez; Maple Shiao; Christopher J. Sipe; Nikolas G. Toman; Joseph Voth; Hui Xie; Clifford J. Steer; Walter C. Low

doi:10.1177/0963689719845351

Interspecies Organogenesis for Human Transplantation

Andrew T. Crane, Rajagopal N. Aravalli, Atsushi Asakura, Andrew W. Grande, Venkatramana D. Krishna, Daniel F. Carlson, Maxim C.J. Cheeran, Georgette Danczyk, James R. Dutton, Perry B. Hackett, Wei Shou Hu, Ling Li, Wei Cheng Lu, Zachary D. Miller, Timothy D. O’Brien, Angela Panoskaltsis-Mortari, Ann M. Parr, Clairice Pearce, Mercedes Ruiz-Estevez, Maple ShiaoChristopher J. Sipe, Nikolas G. Toman, Joseph Voth, Hui Xie, Clifford J. Steer, Walter C. Low

Research output: Contribution to journal › Review article › peer-review

16 Scopus citations

Abstract

Blastocyst complementation combined with gene editing is an emerging approach in the field of regenerative medicine that could potentially solve the worldwide problem of organ shortages for transplantation. In theory, blastocyst complementation can generate fully functional human organs or tissues, grown within genetically engineered livestock animals. Targeted deletion of a specific gene(s) using gene editing to cause deficiencies in organ development can open a niche for human stem cells to occupy, thus generating human tissues. Within this review, we will focus on the pancreas, liver, heart, kidney, lung, and skeletal muscle, as well as cells of the immune and nervous systems. Within each of these organ systems, we identify and discuss (i) the common causes of organ failure; (ii) the current state of regenerative therapies; and (iii) the candidate genes to knockout and enable specific exogenous organ development via the use of blastocyst complementation. We also highlight some of the current barriers limiting the success of blastocyst complementation.

Original language	English (US)
Pages (from-to)	1091-1105
Number of pages	15
Journal	Cell transplantation
Volume	28
Issue number	9-10
DOIs	https://doi.org/10.1177/0963689719845351
State	Published - Sep 1 2019

Bibliographical note

Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study is supported in part by National Institute of Diabetes and Digestive and Kidney Diseases Grant 1R01DK117286-01 to C. J. Steer.

Funding Information:
The authors wish to acknowledge Marra Evans who contributed illustrations for the figures. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study is supported in part by National Institute of Diabetes and Digestive and Kidney Diseases Grant 1R01DK117286-01 to C. J. Steer.

Publisher Copyright:
© The Author(s) 2019.

Keywords

blastocyst complementation
development
gene editing
organ bioengineering
transplantation

Access

10.1177/0963689719845351

OpenUrl availability

Full text

Cite this

Crane, A. T., Aravalli, R. N., Asakura, A., Grande, A. W., Krishna, V. D., Carlson, D. F., Cheeran, M. C. J., Danczyk, G., Dutton, J. R., Hackett, P. B., Hu, W. S., Li, L., Lu, W. C., Miller, Z. D., O’Brien, T. D., Panoskaltsis-Mortari, A., Parr, A. M., Pearce, C., Ruiz-Estevez, M., ... Low, W. C. (2019). Interspecies Organogenesis for Human Transplantation. Cell transplantation, 28(9-10), 1091-1105. https://doi.org/10.1177/0963689719845351

Crane, AT, Aravalli, RN, Asakura, A , Grande, AW , Krishna, VD, Carlson, DF, Cheeran, MCJ, Danczyk, G, Dutton, JR , Hackett, PB , Hu, WS, Li, L, Lu, WC, Miller, ZD, O’Brien, TD , Panoskaltsis-Mortari, A , Parr, AM, Pearce, C, Ruiz-Estevez, M, Shiao, M, Sipe, CJ, Toman, NG, Voth, J, Xie, H, Steer, CJ & Low, WC 2019, 'Interspecies Organogenesis for Human Transplantation', Cell transplantation, vol. 28, no. 9-10, pp. 1091-1105. https://doi.org/10.1177/0963689719845351

@article{6e463df00f734f359d98e83cf5c75ebf,

title = "Interspecies Organogenesis for Human Transplantation",

abstract = "Blastocyst complementation combined with gene editing is an emerging approach in the field of regenerative medicine that could potentially solve the worldwide problem of organ shortages for transplantation. In theory, blastocyst complementation can generate fully functional human organs or tissues, grown within genetically engineered livestock animals. Targeted deletion of a specific gene(s) using gene editing to cause deficiencies in organ development can open a niche for human stem cells to occupy, thus generating human tissues. Within this review, we will focus on the pancreas, liver, heart, kidney, lung, and skeletal muscle, as well as cells of the immune and nervous systems. Within each of these organ systems, we identify and discuss (i) the common causes of organ failure; (ii) the current state of regenerative therapies; and (iii) the candidate genes to knockout and enable specific exogenous organ development via the use of blastocyst complementation. We also highlight some of the current barriers limiting the success of blastocyst complementation.",

keywords = "blastocyst complementation, development, gene editing, organ bioengineering, transplantation",

author = "Crane, {Andrew T.} and Aravalli, {Rajagopal N.} and Atsushi Asakura and Grande, {Andrew W.} and Krishna, {Venkatramana D.} and Carlson, {Daniel F.} and Cheeran, {Maxim C.J.} and Georgette Danczyk and Dutton, {James R.} and Hackett, {Perry B.} and Hu, {Wei Shou} and Ling Li and Lu, {Wei Cheng} and Miller, {Zachary D.} and O{\textquoteright}Brien, {Timothy D.} and Angela Panoskaltsis-Mortari and Parr, {Ann M.} and Clairice Pearce and Mercedes Ruiz-Estevez and Maple Shiao and Sipe, {Christopher J.} and Toman, {Nikolas G.} and Joseph Voth and Hui Xie and Steer, {Clifford J.} and Low, {Walter C.}",

note = "Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study is supported in part by National Institute of Diabetes and Digestive and Kidney Diseases Grant 1R01DK117286-01 to C. J. Steer. Funding Information: The authors wish to acknowledge Marra Evans who contributed illustrations for the figures. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study is supported in part by National Institute of Diabetes and Digestive and Kidney Diseases Grant 1R01DK117286-01 to C. J. Steer. Publisher Copyright: {\textcopyright} The Author(s) 2019.",

year = "2019",

month = sep,

day = "1",

doi = "10.1177/0963689719845351",

language = "English (US)",

volume = "28",

pages = "1091--1105",

journal = "Cell transplantation",

issn = "0963-6897",

publisher = "Cognizant Communication Corporation",

number = "9-10",

}

TY - JOUR

T1 - Interspecies Organogenesis for Human Transplantation

AU - Crane, Andrew T.

AU - Aravalli, Rajagopal N.

AU - Asakura, Atsushi

AU - Grande, Andrew W.

AU - Krishna, Venkatramana D.

AU - Carlson, Daniel F.

AU - Cheeran, Maxim C.J.

AU - Danczyk, Georgette

AU - Dutton, James R.

AU - Hackett, Perry B.

AU - Hu, Wei Shou

AU - Li, Ling

AU - Lu, Wei Cheng

AU - Miller, Zachary D.

AU - O’Brien, Timothy D.

AU - Panoskaltsis-Mortari, Angela

AU - Parr, Ann M.

AU - Pearce, Clairice

AU - Ruiz-Estevez, Mercedes

AU - Shiao, Maple

AU - Sipe, Christopher J.

AU - Toman, Nikolas G.

AU - Voth, Joseph

AU - Xie, Hui

AU - Steer, Clifford J.

AU - Low, Walter C.

N1 - Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study is supported in part by National Institute of Diabetes and Digestive and Kidney Diseases Grant 1R01DK117286-01 to C. J. Steer. Funding Information: The authors wish to acknowledge Marra Evans who contributed illustrations for the figures. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study is supported in part by National Institute of Diabetes and Digestive and Kidney Diseases Grant 1R01DK117286-01 to C. J. Steer. Publisher Copyright: © The Author(s) 2019.

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Blastocyst complementation combined with gene editing is an emerging approach in the field of regenerative medicine that could potentially solve the worldwide problem of organ shortages for transplantation. In theory, blastocyst complementation can generate fully functional human organs or tissues, grown within genetically engineered livestock animals. Targeted deletion of a specific gene(s) using gene editing to cause deficiencies in organ development can open a niche for human stem cells to occupy, thus generating human tissues. Within this review, we will focus on the pancreas, liver, heart, kidney, lung, and skeletal muscle, as well as cells of the immune and nervous systems. Within each of these organ systems, we identify and discuss (i) the common causes of organ failure; (ii) the current state of regenerative therapies; and (iii) the candidate genes to knockout and enable specific exogenous organ development via the use of blastocyst complementation. We also highlight some of the current barriers limiting the success of blastocyst complementation.

AB - Blastocyst complementation combined with gene editing is an emerging approach in the field of regenerative medicine that could potentially solve the worldwide problem of organ shortages for transplantation. In theory, blastocyst complementation can generate fully functional human organs or tissues, grown within genetically engineered livestock animals. Targeted deletion of a specific gene(s) using gene editing to cause deficiencies in organ development can open a niche for human stem cells to occupy, thus generating human tissues. Within this review, we will focus on the pancreas, liver, heart, kidney, lung, and skeletal muscle, as well as cells of the immune and nervous systems. Within each of these organ systems, we identify and discuss (i) the common causes of organ failure; (ii) the current state of regenerative therapies; and (iii) the candidate genes to knockout and enable specific exogenous organ development via the use of blastocyst complementation. We also highlight some of the current barriers limiting the success of blastocyst complementation.

KW - blastocyst complementation

KW - development

KW - gene editing

KW - organ bioengineering

KW - transplantation

UR - http://www.scopus.com/inward/record.url?scp=85072716989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072716989&partnerID=8YFLogxK

U2 - 10.1177/0963689719845351

DO - 10.1177/0963689719845351

M3 - Review article

C2 - 31426664

AN - SCOPUS:85072716989

SN - 0963-6897

VL - 28

SP - 1091

EP - 1105

JO - Cell transplantation

JF - Cell transplantation

IS - 9-10

ER -

Interspecies Organogenesis for Human Transplantation

Abstract

Bibliographical note

Keywords

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this